GJIA
VKTX icon

Glass Jacobson Investment Advisors’s Viking Therapeutics VKTX Stock Holding History

Glass Jacobson Investment Advisors’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.5K Hold
1,063
– – 0.01% 352
2026
Q1 		$34.6K Hold
1,063
– – 0.01% 358
2025
Q4 		$37.4K Hold
1,063
– – 0.01% 339
2025
Q3 		$27.9K Hold
1,063
– – 0.01% 363
2025
Q2 		$28.2K Buy
+1,063
New +$28K 0.01% 350
2024
Q4 		– Sell
-375
Closed -$23.7K – 871
2024
Q3 		$23.7K Hold
375
– – 0.01% 470
2024
Q2 		$19.9K Hold
375
– – 0.01% 484
2024
Q1 		$30.8K Buy
+375
New +$16.7K 0.01% 426

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Glass Jacobson Investment Advisors's VKTX Position: Q2 2026 in Review

Glass Jacobson Investment Advisors held its Viking Therapeutics (VKTX) position steady in Q2 2026 at 1,063 shares worth $41.5K. The position accounts for 0.01% of the portfolio, ranked #352.

Glass Jacobson Investment Advisors first reported a position in VKTX in Q1 2024 and has held it in 8 quarters since. 436 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Glass Jacobson Investment Advisors held 1,063 shares of Viking Therapeutics worth $41.5K as of Q2 2026.
  • Glass Jacobson Investment Advisors left its Viking Therapeutics share count unchanged in Q2 2026.
  • Viking Therapeutics made up 0.01% of Glass Jacobson Investment Advisors's portfolio in Q2 2026, its #352 holding.
  • Glass Jacobson Investment Advisors first reported a position in Viking Therapeutics in Q1 2024 and has held it in 8 quarters since.
  • 436 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Glass Jacobson Investment Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.